<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="6.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Oyama, Mark A</style></author><author><style face="normal" font="default" size="100%">Sisson, D David</style></author><author><style face="normal" font="default" size="100%">Prosek, Robert</style></author><author><style face="normal" font="default" size="100%">Bulmer, Barret J</style></author><author><style face="normal" font="default" size="100%">Luethy, Mike W</style></author><author><style face="normal" font="default" size="100%">Fuentes, Virginia Luis</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Carvedilol in dogs with dilated cardiomyopathy.</style></title><secondary-title><style face="normal" font="default" size="100%">Journal of veterinary internal medicine / American College of Veterinary Internal Medicine</style></secondary-title><alt-title><style face="normal" font="default" size="100%">J. Vet. Intern. Med.</style></alt-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Animals</style></keyword><keyword><style  face="normal" font="default" size="100%">Carbazoles</style></keyword><keyword><style  face="normal" font="default" size="100%">Cardiomyopathy, Dilated</style></keyword><keyword><style  face="normal" font="default" size="100%">Dog Diseases</style></keyword><keyword><style  face="normal" font="default" size="100%">Dogs</style></keyword><keyword><style  face="normal" font="default" size="100%">Propanolamines</style></keyword><keyword><style  face="normal" font="default" size="100%">Vasodilator Agents</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2007</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2007 Nov-Dec</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">21</style></volume><pages><style face="normal" font="default" size="100%">1272-9</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">Dilated cardiomyopathy (DCM) is characterized by reduced systolic function, heightened sympathetic tone, and high morbidity and mortality. Little is known regarding the safety and efficacy of beta-blocker treatment in dogs with DCM.</style></abstract><issue><style face="normal" font="default" size="100%">6</style></issue><custom1><style face="normal" font="default" size="100%">http://www.ncbi.nlm.nih.gov/pubmed/18196737?dopt=Abstract</style></custom1></record></records></xml>